About cry cell intl - CCEL
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.
CCEL At a Glance
Cryo-Cell International, Inc.
700 Brooker Creek Boulevard
Oldsmar, Florida 34677
| Phone | 1-813-749-2100 | Revenue | 31.99M | |
| Industry | Other Transportation | Net Income | 402.10K | |
| Sector | Transportation | 2024 Sales Growth | 2.05% | |
| Fiscal Year-end | 11 / 2025 | Employees | 82 | |
| View SEC Filings |
CCEL Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 176.939 |
| Price to Sales Ratio | 2.226 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 11.85 |
| Enterprise Value to EBITDA | 16.756 |
| Enterprise Value to Sales | 2.521 |
| Total Debt to Enterprise Value | 0.16 |
CCEL Efficiency
| Revenue/Employee | 390,074.463 |
| Income Per Employee | 4,903.598 |
| Receivables Turnover | 4.376 |
| Total Asset Turnover | 0.508 |
CCEL Liquidity
| Current Ratio | 0.581 |
| Quick Ratio | 0.551 |
| Cash Ratio | 0.162 |
CCEL Profitability
| Gross Margin | 73.641 |
| Operating Margin | 11.852 |
| Pretax Margin | 8.767 |
| Net Margin | 1.257 |
| Return on Assets | 0.639 |
| Return on Equity | N/A |
| Return on Total Capital | -142.538 |
| Return on Invested Capital | N/A |
CCEL Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | -4,584.919 |
| Total Debt to Total Assets | 19.998 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | -3,124.846 |